EXORPHIA
Protecting Health with Nature's Drug
Tokyo, Japan · Founded 2019
- Headquarters
- Tokyo
- Employees
- 1–10
- Founded
- 2019
- Business Model
- B2B
- Website
- exorphia.com
About
EXORPHIA is a Tokyo-based biotechnology company developing extracellular vesicle (EV) technology for reproductive medicine. Its lead product is an acellular EV-containing supplement for in vitro fertilization (IVF) embryo culture, designed to improve embryo quality and IVF outcomes. Founded in 2019, the company collaborates with leading Japanese academic institutions including the University of Tokyo and Mie University.
Summary
EXORPHIA is a Biotech company based in Tokyo, Japan, founded in 2019.
Tech & App Stack
2 technologies & apps tracked
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Biopharmaceutical services company
Specialty pharmaceutical company